30 Years of Groundbreaking Science, Training, and Innovation

Satellite Programs

Leading the Way as TAVR Becomes the Gold-Standard for Treating AS (A Case-Based Discussion)

Presentation Theater Program

09/22/2018 13:00:00 09/22/2018 14:00:00 Leading the Way as TAVR Becomes the Gold-Standard for Treating AS (A Case-Based Discussion) TCT 2017 true MM/DD/YYYY TCT 2014 Satellite Symposia - Presentation Theater Program

Saturday, September 22, 2018
Program: 1:00 pm-2:00 pm
San Diego Convention Center, Presentation Theater 1

Leading the Way as TAVR Becomes the Gold-Standard for Treating AS (A Case-Based Discussion)

Leading the Way as TAVR Becomes the Gold-Standard for Treating AS (A Case-Based Discussion)

Sponsored by Cardiovascular Research Foundation

Supported through an educational grant from Edwards Lifesciences

The Cardiovascular Research Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Cardiovascular Research Foundation designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Chairs  

Martin B. Leon, MD

NewYork-Presbyterian/Columbia University Medical Center

New York, NY

 

John G. Webb, MD

St. Paul's Hospital

Vancouver, Canada

Faculty  

Megan Coylewright, MD, MPH

Dartmouth-Hitchcock Medical Center

Lebanon, NH

 

Tsuyoshi Kaneko, MD

Brigham and Women's Hospital

Boston, MA

 

Sandra Lauck, PhD, RN

St. Paul's Hospital

Vancouver, Canada

 

Wilson Y. Szeto, MD

University of Pennsylvania

Philadelphia, PA

 

Vinod H. Thourani, MD

Medstar Heart and Vascular Institute

Washington, DC

 

David A. Wood, MD

Centre for Heart Valve Innovation, Vancouver

Vancouver, Canada

Agenda

Session 1: Shared Decision-Making (SDM) Best-Practices and Challenges in Patient Treatment Pathways Associated with TAVR/SAVR Access Differences

1:00 pm

An SDM Primer for TAVR

Megan Coylewright

1:08 pm

Patient Access Challenges Secondary to Current TAVR/SAVR Site Availability

Tsuyoshi Kaneko

1:15 pm

Discussion

Moderator : Wilson Y. Szeto

Session 2: Procedural and Patient Management Efficiencies

1:20 pm

Brief “3M-Like” Case Presentation Articulating the Minimalist Credo

David A. Wood

1:27 pm

Changes Necessary to Transform TAVR into a Gold-Standard Therapy

Sandra Lauck

1:34 pm

Gentle Warning Against “Extreme Minimalism” Strategies

Martin B. Leon

1:39 pm

Discussion

Moderator : Vinod H. Thourani

Session 3: New TAVR Technology Highlights

1:45 pm

SAPIEN 3 Ultra Case and Technology

John G. Webb

1:52 pm

CENTERA is Next on the Horizon

Martin B. Leon

1:57 pm

Discussion

Moderator : John G. Webb

2:00 pm

Adjourn